Xueyuan Zeng
State Key Laboratory Of Molecular Vaccinology And Molecular Diagnostics & Center For Molecular Imaging And Translational Medicine, 4221-116 Xiang'An South Rd
Xiamen, 361102, China
Xiamen, 361102, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Enhanced therapeutic efficacy of sequential ¹⁷⁷Lu/²²⁵Ac-LNC1004 FAP-targeted radionuclide therapy combined with anti-PD-L1 blockade in pancreatic cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 29, 2025
Development of Preladenant-Based Radiotracers for Imaging A2AR in Tumors.
Journal: Journal of medicinal chemistry
Published: July 22, 2024
Rational Design and Pharmacomodulation of 18F-Labeled Biotin/FAPI-Conjugated Heterodimers.
Journal: Journal of medicinal chemistry
Published: May 10, 2024
68Ga-Labeled TMTP1 Modified with d-Amino Acid for Positron Emission Tomography Diagnosis of Highly Metastatic Hepatocellular Carcinoma.
Journal: Journal of medicinal chemistry
Published: January 25, 2024
Synthesis, preclinical, and initial clinical evaluation of integrin αVβ3 and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [68Ga]Ga-RGD-RM26-03.
Journal: European journal of nuclear medicine and molecular imaging
Published: October 30, 2023
Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 25, 2022
PD-L1-Targeted Radionuclide Therapy Combined with αPD-L1 Antibody Immunotherapy Synergistically Improves the Antitumor Effect.
Journal: Molecular pharmaceutics
Published: June 02, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026